JPS60136505A - Cosmetic - Google Patents

Cosmetic

Info

Publication number
JPS60136505A
JPS60136505A JP17755383A JP17755383A JPS60136505A JP S60136505 A JPS60136505 A JP S60136505A JP 17755383 A JP17755383 A JP 17755383A JP 17755383 A JP17755383 A JP 17755383A JP S60136505 A JPS60136505 A JP S60136505A
Authority
JP
Japan
Prior art keywords
effect
androstene
cosmetic
ethylene ketal
acne
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP17755383A
Other languages
Japanese (ja)
Inventor
Tomomi Okazaki
岡崎 具視
Masaru Suetsugu
勝 末継
Atsushi Kino
木野 淳
Yoshiharu Tsuji
善春 辻
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP17755383A priority Critical patent/JPS60136505A/en
Publication of JPS60136505A publication Critical patent/JPS60136505A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE:To provide a cosmetic free from the undesirable side effect such as the hormonic effect, and having excellent hair-tonic effect and remedying effect of acne, by using 4-androstene-3,17-dione-17-cyclic ethylene ketal as an active component. CONSTITUTION:The objective cosmetic contains about 0.0001-2wt% 4-androstene-3,17-dione-17-cyclic ethylene ketal of formula which is an odorless white or light yellowish white powder obtained as an intermediate in the production of 17beta-(2-hydroxyethoxy)-4-androsten-3-one. The compound of formula has excellent effect to inhibit the reductase activity and inhibit the bond of a receptor protein and 5alpha-DHT compared with know 4-androsten-3-one-17beta-carboxylic acid.

Description

【発明の詳細な説明】 本発明はホルモン作用等の好ましくない副作用を有さず
、かつ優れた養毛効栗、アクネの治療効果をもつ化粧料
に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a cosmetic that does not have undesirable side effects such as hormonal effects and has excellent hair-nourishing effects and acne treatment effects.

禿や脱毛、あるいは脂漏、アクネなどの生理学1゛の徴
候は、男性ホルモンの過剰蓄積に基づ<U:pl: +
lルモン刺激の増大によると言われているが最近、毛根
、皮脂腺等の器官におけるこの男性ホルモンIJj性の
本体は、これら標的器官においてテストステ11ンがテ
ストステロン−5α−レダクターゼという名の酊&;(
以下、レダクターゼと略ず。)によって還元された5α
〜ジヒトl’lデストステロン(以下、5α−D II
 Tと略ず、、)であることが周知きなってきている。
Physiological symptoms such as baldness, hair loss, seborrhea, and acne are based on excessive accumulation of male hormones.
It is said that this is due to increased stimulation of the male hormone IJj, but recently, the main body of this male hormone IJj in organs such as hair roots and sebaceous glands has been shown to be affected by a hormone called testosterone-5α-reductase in these target organs.
Hereinafter abbreviated as reductase. ) reduced by 5α
~Dihuman l'l destosterone (hereinafter referred to as 5α-D II
It is becoming well known that this is abbreviated as T.

即ち、M丸や副NYで作られたテストステロン(男性:
1.ルモン)は血流にのって皮脂腺に行き、皮脂腺細胞
の中にあるレダクターゼによって、より強力な男性ホル
モンである5α−D II Tに変換される。この5α
−■)II Tは細胞内の受容体と結合し、核に働いて
皮脂腺細胞の増殖を促す一方、毛[工細胞に働いてその
細胞分裂を抑制し、毛の成長をさまたげるものとされて
いる。
In other words, testosterone (for men:
1. rumon) travels through the bloodstream to the sebaceous glands, where it is converted into the more potent male hormone 5α-D II T by reductase in the sebaceous gland cells. This 5α
-■) II T binds to intracellular receptors and acts on the nucleus to promote the proliferation of sebaceous gland cells, while acting on hair [engineering cells] to suppress their cell division and hinder hair growth. There is.

従って、禿や脱毛あるいは脂漏、アクネなどの徴候は、
レダクターゼの活性を阻害すること、および5α−D 
II Tと受容体タンパクとの結合を阻害することによ
り低減または!/j +1:することができると考えら
れ、この観点にh(づいてこれまでにいくつかの物質が
見い出されている。しかし、これらの物質はレダクター
ゼ活性の阻害率は大きくても好ましくない副作用があっ
たり、5α−D II Tと受容体タンパクとの結合阻
害率が非常に低が−1たすするという欠点を自−してい
た。従って、これらを実用に供しても霞毛効果、アクネ
の治療効果は良好とは言えず、満足し得るものではなか
った。
Therefore, signs of baldness, hair loss, seborrhea, acne, etc.
inhibiting the activity of reductase and 5α-D
Reduced by inhibiting the binding between II T and receptor protein or! /j +1: Based on this point of view, several substances have been discovered so far. However, although these substances have a high inhibition rate of reductase activity, they have undesirable side effects. They also had the disadvantage that the rate of inhibition of the binding between 5α-D II T and receptor protein was very low, which was less than -1.Therefore, even if these were put to practical use, there would be no hazy effect, The therapeutic effect for acne could not be said to be good and was not satisfactory.

本発明者らは、上記事情に鑑み、ホルモン作用等の好ま
しくない副作用を持たず、安全で、かつレダクターゼ活
性の阻害と、5α−D 11 Tと受容体タンパクとの
結合阻害の両方の効果を併せ持つ物質を探究し、これを
配合することにより養毛効果、およびアクネの治療効果
に優れた化粧料を得るべく鏡台研究を!■ねた結果、4
−アンドロステン−3,17−シオノー17−サイクリ
ックエチレンケタールを配合することにより」ニ記目的
が達成できることを見い出【2、本発明を完成するに至
った。
In view of the above circumstances, the present inventors have developed a method that is safe, does not have undesirable side effects such as hormonal effects, and has the effect of inhibiting both reductase activity and binding of 5α-D 11 T to receptor protein. By exploring the substances that have the same properties, and by blending them together, we conducted research on the mirror table in order to obtain cosmetics with excellent hair growth and acne treatment effects! ■Result of sleeping, 4
It has been found that the objects mentioned above can be achieved by blending -androstene-3,17-cyono-17-cyclic ethylene ketal.[2] The present invention has been completed.

すなわち本発明は、■−アンドロステンー3.17−シ
オンー17−−1Jイタリックエチレンヶタールをa自
することを特徴とする化粧料である。
That is, the present invention is a cosmetic characterized by containing (1)-androstene-3,17-sion-17--1J italic ethylene tar.

以下本発明の+11If成について詳述する。The +11If configuration of the present invention will be described in detail below.

本発明に用いられる4−アント「1ステン−3,I7−
シオンー17−ザイクリツクエチレンリタールは、下記
構造式 をイrする化合物で、17β−(2−ヒト[!−トシェ
トー1゜シ)−トアントロステンー3−オンを製造する
際の中間体として得られる白色灰量淡黄白色の粉末で、
無臭である。
4-ant "1 sten-3, I7-" used in the present invention
Zion-17-zylic ethylenerital is a compound having the following structural formula, and is obtained as an intermediate in the production of 17β-(2-human[!-tsheto1゜shi)-antrosten-3-one. White gray: Pale yellowish white powder.
It is odorless.

4−アンドロステン−3,17−シオンー17−サイク
リックエチレンケタールの配合量は、本発明の化粧料中
o、o0o1〜2重量%程度である。
The blending amount of 4-androstene-3,17-sion-17-cyclic ethylene ketal is about 1 to 2% by weight of the cosmetic composition of the present invention.

本発明に係る化粧料には4−アンドロステン−3、I7
−ジオン−1フーーリ°イクリツクエチレンケタールの
ほか、通常化粧料に用いられる添加剤たとえげ、ヒノキ
チオール、へキザクロロフェン、フッノール、ペンザル
コニウムク「1リド、セチルピリジニウムクロリド、ウ
ンデシレン酸、トリクB ++ IJルバニリト、およ
びビチオノール等の抗菌剤、メントール等の清涼剤、サ
リチル酸、亜鉛おJ、びその化合物、乳酸およびそのア
ルキルエステル等の薬剤、オリーブ油、スクワラン、流
動l(ラフイン、イソプロピルミリステート、高級脂肪
酸、高級アル;1−ル等の油分、その他界面活性剤、香
料、酸化防止剤、紫外線吸収剤、色素、エタノール、水
、保湿剤、増ネ1i剤等が本発明の効果を損わない範囲
で適宜配合することができる。
The cosmetics according to the present invention include 4-androstene-3, I7
In addition to ethylene ketal, additives commonly used in cosmetics include hinokitiol, hexachlorophene, fluorinol, penzalkonium chloride, cetylpyridinium chloride, undecylenic acid, trichloride, and other additives commonly used in cosmetics. B ++ Antibacterial agents such as IJ rubanirite and bithionol, cooling agents such as menthol, drugs such as salicylic acid, zinc chloride, bisodium compounds, lactic acid and its alkyl esters, olive oil, squalane, liquid l (rough-in, isopropyl myristate, high-grade Fatty acids, oils such as higher alcohols, other surfactants, fragrances, antioxidants, ultraviolet absorbers, pigments, ethanol, water, humectants, thickening agents, etc. do not impair the effects of the present invention. It can be blended as appropriate within the range.

本発明の化訓料の性状は、クリ−!・、「1−ジョン等
外皮に適用できるVi状のものであればいずれでも良い
The properties of the chemical training material of the present invention are as follows: Cree!・Any Vi-shaped material that can be applied to the outer skin, such as 1-john, may be used.

次に本発明に用いる4−アンドロステン−3,17−シ
オンー17−・す・イタリックエチレンケタールのレダ
クターゼ活性阻害効宋および受容体タンパクと5α−D
 If Tとの結合阻害効果について比較例をあげて説
明する。
Next, we will discuss the inhibitory effect of 4-androstene-3,17-sion-17-su-italic ethylene ketal on reductase activity, receptor protein, and 5α-D.
The effect of inhibiting binding with If T will be explained by giving a comparative example.

レダクターゼ活性阻害効果 高安らの方法(西日率皮膚科学会誌、43、l215−
1217.198])にもとづき、ハムスターの背中の
皮脂腺を用い、テストステロンが5α−1) II T
 k: 還元される量を測定した。実験に供した試料濃
度は10−モル濃度である。得られたデータカ弓次式を
用いて阻害率をめた。結果を表1に示す。
Reductase activity inhibition effect Takayasu's method (Journal of the Japanese Society of Dermatology, 43, l215-
1217.198]), using the sebaceous glands on the back of hamsters, testosterone was determined to be 5α-1) II T
k: The amount reduced was measured. The sample concentration used in the experiment was 10-molar. The inhibition rate was determined using the obtained data and the Yuji equation. The results are shown in Table 1.

阻害率(%)= (C−i/C)XIooC::=Iイ
ンロールの5α−1) II Tの生成量 t:試料を添加した時の5α−D II Tの生成量 去1 ジ容体タンパクと5α−I) II Tとの結合阻害効
果TakayasuらのJJ法 (八rch、Dcr+
+ato1.Res、、2F+4.50−51、In7
!l)にもとづき、受容体タンパクと5α−1) II
 Tとの結合f+[を?l1lI定した。実験に供した
6 試料濃度は10 モル10度である。得られたデータか
ら次式を用いて阻害率をめた。結果を表2Cご示ず。
Inhibition rate (%) = (C-i/C) Inhibitory effect of binding between protein and 5α-I) II T Takayasu et al.'s JJ method (8rch, Dcr+
+ato1. Res,, 2F+4.50-51, In7
! l) Based on the receptor protein and 5α-1) II
The combination f+[ with T? l1lI was determined. The concentration of the 6 samples used in the experiment was 10 mol 10 degrees. The inhibition rate was calculated from the obtained data using the following formula. The results are not shown in Table 2C.

阻害率(%)= (C−t/C) xlooC: :ア
ンド[1−ルの受容体タンパクと5α−D II Tと
の結合量 t:試料を添加した時の受容体タンパ クと5α−D II Tとの結合置 去1および表2から明らかなように4−アンドロステン
−3,17−シオンー17−ザイクリソクコーヂレンケ
タールは、従来公知の4−アンド11スデンー3−オン
−17β−カルボン酸に比べてレダクターゼ活性の阻害
効果、および受容体タンパクと5α−D II Tとの
結合阻害効果か優れており、本発明の[1的を達成する
物質であるといえる。従って、4−アンドロステン−3
,17−ジオン−1フーーリ゛イタリツクエチレンゲク
ールを配合した本発明の化枳料の養毛効果、およびアク
ネの治療効果は大なることが期待された。
Inhibition rate (%) = (C-t/C) As is clear from the bonding position 1 with II T and Table 2, 4-androstene-3,17-sion-17-zyrysoccordylene ketal is a compound of the conventionally known 4-androstene-3,17-sion-17-17β-carboxylic compound. Compared to acids, it has a superior effect of inhibiting reductase activity and binding of receptor protein to 5α-D II T, and can be said to be a substance that achieves the first objective of the present invention. Therefore, 4-androstene-3
, 17-dione-1 It was expected that the cosmetic composition of the present invention containing ethylene glycol would have a greater effect on hair growth and treatment of acne.

次に実施例をあげて本発明をさらに;Y細に説明する。Next, the present invention will be explained in further detail with reference to Examples.

本発明はこれにより限5jpされるものではない。配合
量は重量%である。
The present invention is not limited to this. The blending amount is in weight%.

まず、谷毛料としての実施例を述べるが、これに先たち
試験法を説明する。
First, an example will be described as a tani hair dye, and then a test method will be explained.

養毛効果Ml+定法 化粧料使用前後の洗娶時脱毛本数の変化で判定した。被
験者は実施例1〜3および比較例1の謂4 Ml頚(2
) 各々のIiYごとに10名とした。1nll 5i
4期間は、1力月間とし、最初の2力月間は化粧料無塗
布の期間、後下の2力月間を化粧料塗布の期間とし、こ
の間、21−1おきに洗髪し、1週間に1底抜毛を回収
しその本数を数えた。各期間の抜毛本数の表z%は、化
粧料無塗布の2ノ1月間、;IIB回の抜毛本数のデー
タと化粧1f′1塗布の2力月間、818回の抜毛本数
のデータを夫々の期間ごとにまとめ、平均イー°【+α
の形で1回当りの抜毛本数として表示した。中位は本で
ある。効果の判定は、夫々の期間の十均植の差から次の
ように表示した。
The hair growth effect was determined by Ml + the change in the number of hairs removed during washing before and after using the regular cosmetics. The subjects tested the so-called 4 Ml neck (2
) There were 10 people for each IiY. 1nll 5i
The fourth period is one month, and the first two months are the period of no cosmetic application, and the second two months are the period of applying cosmetics.During this period, wash your hair every 21-1 days and wash your hair once a week. The bottom hairs were collected and counted. The table z% of the number of hairs pulled in each period is based on the data of the number of hairs pulled out for 2 months without applying cosmetics; Summarized by period, average E° [+α
It was expressed as the number of hairs pulled per session. In the middle are books. The effectiveness was evaluated based on the difference in planting times for each period as follows.

++:抜毛木数が70本以」二減っており箸しい効果を
認めた。
++: The number of hairs removed was reduced by 70 or more, and a significant effect was observed.

十二抜毛木数か40本以上減っておりかなりの効果を認
めた。
The number of hairs removed was reduced by more than 40, indicating a significant effect.

土:抜毛本数が10本以−に減っておりやや効果ありと
いえた。
Soil: The number of hairs pulled was reduced to 10 or more, indicating that it was somewhat effective.

一:抜毛本数の減少が10本末漕であり効果ありとはい
えない。
1: The number of hairs pulled was reduced by 10, so it cannot be said that it is effective.

実施例1〜3、比較例1 (ツツ 造 2人 ) 95%エタノールに4−アット【Iステン−3+17−
シオンー17−ザイクリツクエチレンケータール、およ
び硬化ヒマシ浦EO40モル付加物を添加し、撹H′溶
解させ、次いでイオン交換水を添加、混合して実施例1
の透明液伏の化1if:lを得た。実施例2.3、比較
例1も実施例1と同様にして製造した。
Examples 1 to 3, Comparative Example 1 (Tsuzo 2 people) 4-at[I-Sten-3+17-] in 95% ethanol
Example 1: Shion-17-Zyrikku ethylene ketal and 40 mol adduct of hardened Castor EO were added, dissolved by stirring, and then ion-exchanged water was added and mixed.
A clear liquid solution of 1if:l was obtained. Examples 2.3 and Comparative Example 1 were also produced in the same manner as Example 1.

(結果) 特開昭1;0−136505 (4) 前述した結果は全て、4−アンドロステン−3,17−
シオンー17−ザイクリツクエチレンケタール配合の本
発明に係る化粧料が従来公知のしγントロスデノー3−
オンー17β−カルボン酸を配合した化訓料に比しても
、その養毛効果が優れていることを示している。
(Results) JP-A-1:0-136505 (4) All the above results are based on 4-androstene-3,17-
The cosmetics according to the present invention containing Zion-17-zylic ethylene ketal are the same as the conventional cosmetics containing Zion-17-zylic ethylene ketal.
This shows that the hair-nourishing effect is superior to that of a chemical formula containing on-17β-carboxylic acid.

さらに実施例をあげてアクネの治療効果についてもli
Y細に説明する。配合料は重量%である。
Furthermore, I will give examples and explain the therapeutic effects of acne.
Explain in detail. Ingredients are in weight percent.

(使用化訓料−実施例4) 卜記処方、!’!I 進法で得たローションタイプの化
粧F1を使用した。
(Using training - Example 4) Bokuji prescription! '! I used lotion type makeup F1 obtained using the I base method.

4−アンドロステン−3,17−シオンー17−サイク
リツクニチレンケタール0.25g1ポリオキシェチレ
7(GOfル)硬化ヒマシ油2.0g、グリセリン10
.0g、ジプロピレングリコールto、og、1.3−
ブヂレングリフl−ル5.0g、および5.0gのポリ
エチレンクリ:1−ルl500を60℃で加熱溶解する
。これにセヂルインオクタノエートIO,OL スクヮ
ラン5.0gおよびメチルパラベン1.3gを同じ<0
0”Cに加熱溶解したものを添加混合し、ボモミキザー
処理してゲルを作る。次にこのゲルにカルボ−1−ジビ
ニルポリマー0.3gおよびヘキザメタリン酸ソーダ0
.03gをイオン交換水11.0gに溶解せしめたもの
を徐添加し、ホモミキザーで分散した抜水酸化カリウノ
・0.12gをイオン交換水40.0gに溶解したもの
を添加混合し、ホモミキザーで乳化してローションタイ
プの化訓料を得た。
4-androstene-3,17-sion-17-cyclic nitylenic ketal 0.25 g 1 polyoxyethylene 7 (GOF) hydrogenated castor oil 2.0 g, glycerin 10
.. 0g, dipropylene glycol to, og, 1.3-
5.0 g of butylene glycol 1-ol and 5.0 g of polyethylene 1-ol 1500 are heated and melted at 60°C. To this, add 5.0 g of cedilline octanoate IO, OL squalane and 1.3 g of methylparaben to the same <0
Add and mix the heated solution to 0"C and process with a vomomi mixer to make a gel. Next, 0.3 g of carbo-1-divinyl polymer and 0.3 g of sodium hexametaphosphate are added to this gel.
.. 03g dissolved in 11.0g of ion-exchanged water was slowly added, and 0.12g of hydrated potassium uno dispersed with a homomixer was dissolved in 40.0g of ion-exchanged water, and then mixed, and emulsified with a homomixer. I got a lotion type chemical training fee.

(使用対象) 15〜32歳までの男女計20名を一群とした。(Target for use) The group consisted of 20 men and women between the ages of 15 and 32.

(使用方法) 化粧石帥を用いて顔面をよく洗浄した後、皮疹の」二に
のみ、前記したローションタイプの化粧料を10に1〜
3回塗布せしめた。
(How to use) After thoroughly washing your face with a cosmetic soap, apply the above-mentioned lotion-type cosmetics at 1 to 10 times only on the skin rash.
It was applied three times.

(観察項[1および観察口) 面飽、丘疹、勲厄の3症状について観察し、その個々の
所見の程度をそれぞれ高度(4)、中f′1度に()軽
度(2)、軽微(+)、なしく0)の5段階に分けて工
・ト価した。またこれらの3症吠の程度を総合して尋常
性座府の重篤度を、重症、中等症、軽症ので(段階に分
けた。経過観察は、治療前、治療1週間後、2週間後、
3週間後、4週間後の各回に行った。
(Observation items [1 and observation port] Observe the three symptoms of skin irritation, papules, and rashes, and rate the severity of each finding as severe (4), moderate (2), mild (2), and mild (2). The evaluation was divided into 5 levels: (+), none (0). In addition, the severity of Zafu vulgaris was divided into severe, moderate, and mild levels by combining the severity of these three symptoms.Follow-up was conducted before treatment, 1 week after treatment, and 2 weeks after treatment. ,
The test was repeated 3 weeks later and 4 weeks later.

(全般敗訴1σ) 使用+’+i+に比較して使用化粧料にょる症吠の改善
度、著しく軽快(世)、かなり軽快(什)、やや軽快(
+)、不変(±)、増悪(−)の5段階に分けた。
(Overall loss 1σ) Compared to using +'+i+, the degree of improvement in symptoms caused by the cosmetics used was markedly relieved (world), considerably relieved (什), and somewhat relieved (
It was divided into 5 stages: +), unchanged (±), and worsened (-).

(6川性) 1゛般改冴度から、きわめて有用(世)、かなりイr用
(什)、ややイI’ Jll (”)、無効(±)と判
定した。
(6th grade) Based on the 1゛ general improvement level, it was judged as extremely useful (world), quite useful (ti), somewhat good (''), and invalid (±).

(円、下余白) テスト結果から明らかなように、4−アンドロス−J/
−:l、 +7−ジオ/−17−’Jイタリックエチレ
ンケタールを配合した本発明に係る化粧料は、アクネの
治療効果に4glれていることが立証された。
(Circle, bottom margin) As is clear from the test results, 4-Andros-J/
-:l, +7-dio/-17-'J The cosmetic composition according to the present invention containing italic ethylene ketal was proven to have a therapeutic effect on acne by 4gl.

実施例5 エタノール55.0gにポリ」キシエチレン(8干ル)
オレイルアルコールエーテル2.0g、4−アンドロス
テン−3,17−シオンー17−サイクリツクニチレン
ゲクール0.05g、ヒノキチオール0.05gを加え
、これに香料、染料を夫々適量加えて溶解したのち、イ
オン交換水42.409gを加えて可溶化し化粧料を得
た。
Example 5 Poly'xyethylene (8 liters) in 55.0 g of ethanol
Add 2.0 g of oleyl alcohol ether, 0.05 g of 4-androstene-3,17-sion-17-cyclic Nichirengekool, and 0.05 g of hinokitiol, add appropriate amounts of fragrance and dye, and dissolve. 42.409 g of exchange water was added to solubilize the mixture to obtain a cosmetic.

この化11料を実施例1〜3と同様に実使用テストを行
ったところ、その養毛効果が優れていることが確認され
た。
When this compound No. 11 was subjected to a practical use test in the same manner as in Examples 1 to 3, it was confirmed that the hair growth effect was excellent.

実施例6 番−アンドI+ステンー3.17−シオンー17−サイ
クリツクニチレンケタール0.5g、ポリオキシエチレ
ン(00fル)硬化ヒマシ浦2.0g1グリセリン10
.0g1ジプロピレングリコールI0.0g、および1
.3−ブヂレングリコール5.0gと、5.0gのポリ
エチレングリコール1500とを60℃で加熱溶解する
(A部)。セチルイソオクタノエートIO,0g1 ス
クワラン5.0g1 ワセリン2.0g1およびブ11
ピルパラベン2.0gを60℃で加熱溶解する( 11
部)。カルボキシビニルポリマー1%水溶液30.0g
および・\キザメタリン酸ソーダ0.03gをイオン交
換水8.415gに溶解する(0部)。A部と0部とを
60°Cにて混合し;1、モミキ・す°−処理しゲルを
作る。これにイオン交換水5.0gを徐添加し;1、モ
ミキザーで分散する。次にこれに0部を加え、最後にカ
セイカリ0、’12gをイオン交換水5.0gに溶かし
た水溶i1kを添加しホモミキザーで乳化してO/W乳
液乳液化粧料を得た。
Example 6 - And I + Stain 3.17-Sion-17-Cyclic Nitylene Ketal 0.5g, Polyoxyethylene (00F) Hardened Castor 2.0g 1 Glycerin 10
.. 0g1 dipropylene glycol I0.0g, and 1
.. 5.0 g of 3-butylene glycol and 5.0 g of polyethylene glycol 1500 are heated and dissolved at 60°C (Part A). Cetyl isooctanoate IO, 0g1 Squalane 5.0g1 Vaseline 2.0g1 and Bu 11
Heat and dissolve 2.0g of pilparaben at 60℃ (11
Department). Carboxyvinyl polymer 1% aqueous solution 30.0g
and・Dissolve 0.03 g of sodium chloride metaphosphate in 8.415 g of ion-exchanged water (0 parts). Mix Part A and Part 0 at 60°C; 1. Treat with rice milling to form a gel. Gradually add 5.0 g of ion-exchanged water to this; 1. Disperse with a mixer. Next, 0 part was added to this, and finally, a water-soluble i1k prepared by dissolving 0.12 g of caustic potash in 5.0 g of ion-exchanged water was added and emulsified with a homomixer to obtain an O/W emulsion emulsion cosmetic.

本化粧料を実施例4と同様にテストを行った結果、アク
ネの治療効果が確認された。
As a result of testing this cosmetic in the same manner as in Example 4, it was confirmed that it has a therapeutic effect on acne.

実施例7 ?AI: 動パラフィン5.0g、セトステアリルアル
コール5.5g、ワセリン5.5g、グリセリルモノス
テアレート3.0gs ポリオキシエチレン(20fル
)2−オクチルトデンルエーテル3.0g、ビタミンE
アセ、−ト0.05g、ブ11ビルパラベン0.3gお
よび香料(1,05gを加熱溶解、混合する。これに4
−アンド+1スブン−3,17−シオンー17−ザイク
リツクエチレンゲクール0.5g、グリセリン7.0g
s ジプロピレングリコ1−ル20.0g15.0gの
ポリエチレングリ;1−ル4000、へキザメタリン酸
ソーダ0.005gおよびイ詞ン交換水45.095g
の加熱溶解混合物を添加し、;1モミートザーにて乳化
してクリーム吠化粧料を得た。 得られた化粧料は、養
毛効果、アクネの治療効果に伝れていた。
Example 7? AI: 5.0 g of dynamic paraffin, 5.5 g of cetostearyl alcohol, 5.5 g of petrolatum, 3.0 gs of glyceryl monostearate, 3.0 g of polyoxyethylene (20 fl) 2-octyltodelene ether, vitamin E
Heat and dissolve 0.05 g of acetate, 0.3 g of butylparaben, and fragrance (1.05 g).
-and+1subun-3,17-thion-17-zylic ethylene gel 0.5g, glycerin 7.0g
s 20.0 g of dipropylene glycol 15.0 g of polyethylene glycol; 4000 g of dipropylene glycol, 0.005 g of sodium hexametaphosphate and 45.095 g of dioxygen-exchanged water.
The heated and dissolved mixture was added and emulsified using a one-millimeter massager to obtain a cream cosmetic. The resulting cosmetics were reported to have hair-nourishing and acne-treating effects.

Claims (1)

【特許請求の範囲】[Claims] 4−17 )I+ステン−3,17−シオンー17−サ
イクリックエチレンケタールを含有することを特徴とす
る化粧1L
4-17) 1L of makeup characterized by containing I+Sten-3,17-Sion-17-cyclic ethylene ketal
JP17755383A 1983-09-26 1983-09-26 Cosmetic Pending JPS60136505A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17755383A JPS60136505A (en) 1983-09-26 1983-09-26 Cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17755383A JPS60136505A (en) 1983-09-26 1983-09-26 Cosmetic

Publications (1)

Publication Number Publication Date
JPS60136505A true JPS60136505A (en) 1985-07-20

Family

ID=16032963

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17755383A Pending JPS60136505A (en) 1983-09-26 1983-09-26 Cosmetic

Country Status (1)

Country Link
JP (1) JPS60136505A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6284011A (en) * 1985-10-07 1987-04-17 Shiseido Co Ltd Hair tonic

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6284011A (en) * 1985-10-07 1987-04-17 Shiseido Co Ltd Hair tonic

Similar Documents

Publication Publication Date Title
JPS6360910A (en) Skin drug for external use
JPS6127914A (en) Cosmetic
JPS61212512A (en) Hair tonic
KR20200141046A (en) Topical formulations and methods of treatment comprising strontium and methylsulfonylmethane (MSM)
US20060148907A1 (en) Topical antinflammatory preparations of y-terpinene
JPS60136505A (en) Cosmetic
JPS6322510A (en) External preparation for skin
JPH01275516A (en) Dandruff-preventive agent and hair-cosmetic
JPS6360909A (en) Skin drug for external use
JPS60215608A (en) Hair tonic preparation
JP2566792B2 (en) Hair growth and hair growth promoter
KR0153203B1 (en) Cosmetic composition for moisturising and softening
JPS62132810A (en) Cosmetic
JPS6322506A (en) External preparation for skin
JPS6067411A (en) Cosmetic
JPH0577647B2 (en)
JPH0669955B2 (en) External preparation for sebum control
JPS5988407A (en) Hair tonic
JPS6054310A (en) Cosmetic
JPH043363B2 (en)
JPS62169717A (en) Hair cosmetic
JPS6081122A (en) Cosmetic
JPS5988409A (en) Hair tonic
JPS5998010A (en) Hair tonic
JPS5988408A (en) Hair tonic